Kenvue, Inc. ( (KVUE) ) has shared an announcement.

Kenvue, the household staple behind Tylenol, has inked a deal to sell itself to Kimberly-Clark in a $48.7 billion deal. The ...

Even though Kenvue's stock was already in a tailspin before the FDA warned pregnant woman that Tylenol posed a health risk, ...

2025 hasn't been kind to Kenvue (NYSE: KVUE) stock lately. Shares of the one-time Johnson & Johnson unit got hit hard after ...

Kenvue (NYSE:KVUE), the consumer healthcare spin-off from Johnson & Johnson, has experienced a significant decline in its ...

Explore Kenvue Inc. (NYSE:KVUE) trends, dividends, and market activity among consumer stocks in S&P 500 today.

You can follow the latest updates on the market here in our daily live blog. Past midday, 60.9% of the stocks on the U.S.

Kenvue Inc. (NYSE:KVUE) is one of the 10 Stocks Under $20 to Buy According to Analysts. On October 27, Jefferies reduced its ...

Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when ...

You can especially make a lot of money when you invest in stocks with juicy dividend yields in addition to tremendous share ...

Kenvue stock has struggled this year, but an acquisition offer is giving investors hope leading up to this week's earnings ...